Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/19/2021 | Outperform → Market Perform | Northland Capital Markets | |
| 10/19/2021 | $25.00 → $10.00 | Buy → Neutral | HC Wainwright & Co. |
| 10/12/2021 | $20.00 → $12.00 | Outperform → Market Perform | BMO Capital |
| 10/12/2021 | Strong Buy → Market Perform | Raymond James | |
| 10/12/2021 | $14.00 → $10.00 | Outperform → Neutral | Credit Suisse |
| 8/6/2021 | $8.00 → $6.00 | Neutral | Goldman Sachs |
| 8/5/2021 | $20.00 → $18.00 | Buy | Needham |
Northland Capital Markets downgraded Flexion Therapeutics from Outperform to Market Perform
HC Wainwright & Co. downgraded Flexion Therapeutics from Buy to Neutral and set a new price target of $10.00 from $25.00 previously
BMO Capital downgraded Flexion Therapeutics from Outperform to Market Perform and set a new price target of $12.00 from $20.00 previously